Global Eucommia Ulmoides Granules Market Growth 2024-2030

Publication ID:

LPI10250450

Publication Date:

October 15, 2024

Pages:

108

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Eucommia ulmoides granules are a Chinese patent medicine, the main ingredient of which is Eucommia ulmoides leaves. It has the effects of nourishing the liver and kidneys and strengthening the tendons and bones. It can be used to treat symptoms such as low back pain and soreness of the waist and knees due to kidney deficiency. Kidney yin deficiency may cause symptoms such as soreness of the waist and knees, dizziness, tinnitus, insomnia and dreaminess.
The global Eucommia Ulmoides Granules market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淓ucommia Ulmoides Granules Industry Forecast鈥� looks at past sales and reviews total world Eucommia Ulmoides Granules sales in 2023, providing a comprehensive analysis by region and market sector of projected Eucommia Ulmoides Granules sales for 2024 through 2030. With Eucommia Ulmoides Granules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Eucommia Ulmoides Granules industry.
This Insight Report provides a comprehensive analysis of the global Eucommia Ulmoides Granules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Eucommia Ulmoides Granules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Eucommia Ulmoides Granules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Eucommia Ulmoides Granules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Eucommia Ulmoides Granules.
United States market for Eucommia Ulmoides Granules is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Eucommia Ulmoides Granules is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Eucommia Ulmoides Granules is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Eucommia Ulmoides Granules players cover Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd., Huangshan Tianmu Pharmaceutical Co., Ltd., Wuhu Luye Pharmaceutical Co., Ltd., Shandong Buchang Shenzhou Pharmaceutical Co., Ltd., Huiyinbi Group Anhui Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Eucommia Ulmoides Granules market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
5g Per Bag
10g Per Bag
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd.
Huangshan Tianmu Pharmaceutical Co., Ltd.
Wuhu Luye Pharmaceutical Co., Ltd.
Shandong Buchang Shenzhou Pharmaceutical Co., Ltd.
Huiyinbi Group Anhui Pharmaceutical Co., Ltd.
Guizhou Runsheng Pharmaceutical Co., Ltd.
Nanjing Tongrentang Pharmaceutical Co., Ltd.
Guizhou Shengjitang Pharmaceutical Co., Ltd.
Sichuan Shenghe Pharmaceutical Co., Ltd.
Xi'an Zhengda Pharmaceutical Co., Ltd.
Guizhou Shenqi Pharmaceutical Co., Ltd.
Jilin Zixin Pharmaceutical Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Eucommia Ulmoides Granules market?
What factors are driving Eucommia Ulmoides Granules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Eucommia Ulmoides Granules market opportunities vary by end market size?
How does Eucommia Ulmoides Granules break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Eucommia Ulmoides Granules Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Eucommia Ulmoides Granules by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Eucommia Ulmoides Granules by Country/Region, 2019, 2023 & 2030
2.2 Eucommia Ulmoides Granules Segment by Type
2.2.1 5g Per Bag
2.2.2 10g Per Bag
2.3 Eucommia Ulmoides Granules Sales by Type
2.3.1 Global Eucommia Ulmoides Granules Sales Market Share by Type (2019-2024)
2.3.2 Global Eucommia Ulmoides Granules Revenue and Market Share by Type (2019-2024)
2.3.3 Global Eucommia Ulmoides Granules Sale Price by Type (2019-2024)
2.4 Eucommia Ulmoides Granules Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Eucommia Ulmoides Granules Sales by Application
2.5.1 Global Eucommia Ulmoides Granules Sale Market Share by Application (2019-2024)
2.5.2 Global Eucommia Ulmoides Granules Revenue and Market Share by Application (2019-2024)
2.5.3 Global Eucommia Ulmoides Granules Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Eucommia Ulmoides Granules Breakdown Data by Company
3.1.1 Global Eucommia Ulmoides Granules Annual Sales by Company (2019-2024)
3.1.2 Global Eucommia Ulmoides Granules Sales Market Share by Company (2019-2024)
3.2 Global Eucommia Ulmoides Granules Annual Revenue by Company (2019-2024)
3.2.1 Global Eucommia Ulmoides Granules Revenue by Company (2019-2024)
3.2.2 Global Eucommia Ulmoides Granules Revenue Market Share by Company (2019-2024)
3.3 Global Eucommia Ulmoides Granules Sale Price by Company
3.4 Key Manufacturers Eucommia Ulmoides Granules Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Eucommia Ulmoides Granules Product Location Distribution
3.4.2 Players Eucommia Ulmoides Granules Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Eucommia Ulmoides Granules by Geographic Region
4.1 World Historic Eucommia Ulmoides Granules Market Size by Geographic Region (2019-2024)
4.1.1 Global Eucommia Ulmoides Granules Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Eucommia Ulmoides Granules Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Eucommia Ulmoides Granules Market Size by Country/Region (2019-2024)
4.2.1 Global Eucommia Ulmoides Granules Annual Sales by Country/Region (2019-2024)
4.2.2 Global Eucommia Ulmoides Granules Annual Revenue by Country/Region (2019-2024)
4.3 Americas Eucommia Ulmoides Granules Sales Growth
4.4 APAC Eucommia Ulmoides Granules Sales Growth
4.5 Europe Eucommia Ulmoides Granules Sales Growth
4.6 Middle East & Africa Eucommia Ulmoides Granules Sales Growth
5 Americas
5.1 Americas Eucommia Ulmoides Granules Sales by Country
5.1.1 Americas Eucommia Ulmoides Granules Sales by Country (2019-2024)
5.1.2 Americas Eucommia Ulmoides Granules Revenue by Country (2019-2024)
5.2 Americas Eucommia Ulmoides Granules Sales by Type (2019-2024)
5.3 Americas Eucommia Ulmoides Granules Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Eucommia Ulmoides Granules Sales by Region
6.1.1 APAC Eucommia Ulmoides Granules Sales by Region (2019-2024)
6.1.2 APAC Eucommia Ulmoides Granules Revenue by Region (2019-2024)
6.2 APAC Eucommia Ulmoides Granules Sales by Type (2019-2024)
6.3 APAC Eucommia Ulmoides Granules Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Eucommia Ulmoides Granules by Country
7.1.1 Europe Eucommia Ulmoides Granules Sales by Country (2019-2024)
7.1.2 Europe Eucommia Ulmoides Granules Revenue by Country (2019-2024)
7.2 Europe Eucommia Ulmoides Granules Sales by Type (2019-2024)
7.3 Europe Eucommia Ulmoides Granules Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Eucommia Ulmoides Granules by Country
8.1.1 Middle East & Africa Eucommia Ulmoides Granules Sales by Country (2019-2024)
8.1.2 Middle East & Africa Eucommia Ulmoides Granules Revenue by Country (2019-2024)
8.2 Middle East & Africa Eucommia Ulmoides Granules Sales by Type (2019-2024)
8.3 Middle East & Africa Eucommia Ulmoides Granules Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Eucommia Ulmoides Granules
10.3 Manufacturing Process Analysis of Eucommia Ulmoides Granules
10.4 Industry Chain Structure of Eucommia Ulmoides Granules
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Eucommia Ulmoides Granules Distributors
11.3 Eucommia Ulmoides Granules Customer
12 World Forecast Review for Eucommia Ulmoides Granules by Geographic Region
12.1 Global Eucommia Ulmoides Granules Market Size Forecast by Region
12.1.1 Global Eucommia Ulmoides Granules Forecast by Region (2025-2030)
12.1.2 Global Eucommia Ulmoides Granules Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Eucommia Ulmoides Granules Forecast by Type (2025-2030)
12.7 Global Eucommia Ulmoides Granules Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd.
13.1.1 Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Company Information
13.1.2 Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolios and Specifications
13.1.3 Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Main Business Overview
13.1.5 Qinhuangdao Shanhaiguan Pharmaceutical Co., Ltd. Latest Developments
13.2 Huangshan Tianmu Pharmaceutical Co., Ltd.
13.2.1 Huangshan Tianmu Pharmaceutical Co., Ltd. Company Information
13.2.2 Huangshan Tianmu Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolios and Specifications
13.2.3 Huangshan Tianmu Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Huangshan Tianmu Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Huangshan Tianmu Pharmaceutical Co., Ltd. Latest Developments
13.3 Wuhu Luye Pharmaceutical Co., Ltd.
13.3.1 Wuhu Luye Pharmaceutical Co., Ltd. Company Information
13.3.2 Wuhu Luye Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolios and Specifications
13.3.3 Wuhu Luye Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Wuhu Luye Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Wuhu Luye Pharmaceutical Co., Ltd. Latest Developments
13.4 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd.
13.4.1 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Company Information
13.4.2 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolios and Specifications
13.4.3 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Main Business Overview
13.4.5 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Latest Developments
13.5 Huiyinbi Group Anhui Pharmaceutical Co., Ltd.
13.5.1 Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Company Information
13.5.2 Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolios and Specifications
13.5.3 Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 Huiyinbi Group Anhui Pharmaceutical Co., Ltd. Latest Developments
13.6 Guizhou Runsheng Pharmaceutical Co., Ltd.
13.6.1 Guizhou Runsheng Pharmaceutical Co., Ltd. Company Information
13.6.2 Guizhou Runsheng Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolios and Specifications
13.6.3 Guizhou Runsheng Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Guizhou Runsheng Pharmaceutical Co., Ltd. Main Business Overview
13.6.5 Guizhou Runsheng Pharmaceutical Co., Ltd. Latest Developments
13.7 Nanjing Tongrentang Pharmaceutical Co., Ltd.
13.7.1 Nanjing Tongrentang Pharmaceutical Co., Ltd. Company Information
13.7.2 Nanjing Tongrentang Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolios and Specifications
13.7.3 Nanjing Tongrentang Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Nanjing Tongrentang Pharmaceutical Co., Ltd. Main Business Overview
13.7.5 Nanjing Tongrentang Pharmaceutical Co., Ltd. Latest Developments
13.8 Guizhou Shengjitang Pharmaceutical Co., Ltd.
13.8.1 Guizhou Shengjitang Pharmaceutical Co., Ltd. Company Information
13.8.2 Guizhou Shengjitang Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolios and Specifications
13.8.3 Guizhou Shengjitang Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Guizhou Shengjitang Pharmaceutical Co., Ltd. Main Business Overview
13.8.5 Guizhou Shengjitang Pharmaceutical Co., Ltd. Latest Developments
13.9 Sichuan Shenghe Pharmaceutical Co., Ltd.
13.9.1 Sichuan Shenghe Pharmaceutical Co., Ltd. Company Information
13.9.2 Sichuan Shenghe Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolios and Specifications
13.9.3 Sichuan Shenghe Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Sichuan Shenghe Pharmaceutical Co., Ltd. Main Business Overview
13.9.5 Sichuan Shenghe Pharmaceutical Co., Ltd. Latest Developments
13.10 Xi'an Zhengda Pharmaceutical Co., Ltd.
13.10.1 Xi'an Zhengda Pharmaceutical Co., Ltd. Company Information
13.10.2 Xi'an Zhengda Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolios and Specifications
13.10.3 Xi'an Zhengda Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Xi'an Zhengda Pharmaceutical Co., Ltd. Main Business Overview
13.10.5 Xi'an Zhengda Pharmaceutical Co., Ltd. Latest Developments
13.11 Guizhou Shenqi Pharmaceutical Co., Ltd.
13.11.1 Guizhou Shenqi Pharmaceutical Co., Ltd. Company Information
13.11.2 Guizhou Shenqi Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolios and Specifications
13.11.3 Guizhou Shenqi Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Guizhou Shenqi Pharmaceutical Co., Ltd. Main Business Overview
13.11.5 Guizhou Shenqi Pharmaceutical Co., Ltd. Latest Developments
13.12 Jilin Zixin Pharmaceutical Co., Ltd.
13.12.1 Jilin Zixin Pharmaceutical Co., Ltd. Company Information
13.12.2 Jilin Zixin Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Product Portfolios and Specifications
13.12.3 Jilin Zixin Pharmaceutical Co., Ltd. Eucommia Ulmoides Granules Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Jilin Zixin Pharmaceutical Co., Ltd. Main Business Overview
13.12.5 Jilin Zixin Pharmaceutical Co., Ltd. Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂